4,428 results on '"GASTROENTEROLOGISTS"'
Search Results
202. Grip strength measurement in high-volume endoscopists and non-endoscopic working gastroenterologists – an opportunity to prevent musculoskeletal health injury in endoscopists?
- Author
-
Sturm, N., Fichtl, A., Wagner, M., Seufferlein, T., Baumann, F., and Walter, B.
- Subjects
- *
GRIP strength , *GASTROENTEROLOGISTS , *JOB absenteeism - Abstract
This article discusses the prevalence of musculoskeletal health disorders among GI endoscopists and the potential for hand grip strength measurement as a preventive measure. The study compared the hand grip strength of a high-volume endoscopist and a non-endoscopic working gastroenterologist before and after work. The results showed that the average hand grip strength of the endoscopist was not significantly higher than that of the non-endoscopist. However, the non-endoscopist had a significant increase in grip strength after work, while the endoscopist had a significant decrease. The study suggests that further research is needed to develop methods to prevent musculoskeletal health disorders in high-volume endoscopists. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
203. Health-related quality of life in inflammatory bowel disease: a comparison of patients receiving nurse-led versus conventional follow-up care.
- Author
-
Alvestad, Line, Jelsness-Jørgensen, Lars-Petter, Goll, Rasmus, Clancy, Anne, Gressnes, Thomas, Valle, Per Christian, and Broderstad, Ann Ragnhild
- Subjects
- *
INFLAMMATORY bowel diseases , *GASTROENTEROLOGISTS , *CROHN'S disease , *QUALITY of life , *ULCERATIVE colitis - Abstract
Background: Inflammatory bowel disease (IBD), consisting of Crohn's disease (CD) and ulcerative colitis (UC), is a chronic disorder with a considerable negative impact on health-related quality of life (HRQoL). During the past decade, IBD nurse specialists have been increasingly involved in follow-up care of IBD outpatients, in a consultative and coordinating role, closely cooperating with gastroenterologists. Whether patients' HRQoL differs between nurses' follow-up care (NF) and conventional follow-up care (CF) has not been widely researched and the aim of this study was to compare two different follow-up regimes with respect to patients' HRQoL. Methods: This cross-sectional, multicenter study involved seven centers; five organized as CF, two as NF. Results: A total of 304 patients aged 18–80 years, 174 females and 130 males, were included, of whom 140 received care under the NF model and 164 under the CF model. Participants in the NF group had a statistically significant higher median total score on the Inflammatory Bowel Disease Questionnaire (IBDQ) (p-value <.001). This pattern could also be seen in the sub-scores of the different IBDQ domains. Despite a trend of higher IBDQ score in all domains in the NF model, the overall result in our study did not reach the limit of 16 points, defined as clinically significant. A higher proportion of NF patients had IBDQ scores defined as remission, as well as a statistically significant higher frequency of outpatient check-ups during a two-year follow-up period. Conclusions: Nurse-led models are not inferior to conventional models with regards to patient reported HRQoL except in the social domain where the model showed to be clinically significant better. Further studies are needed to advance efforts to implement these models and increase access to IBD care. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
204. Australasian paediatric gastroenterologist practices of coeliac disease diagnosis before and during the COVID‐19 pandemic.
- Author
-
Ho, Shaun S C, Evans, Helen M, Roberts, Amin J, Thapar, Nikhil, Dutt, Shoma, Thacker, Kunal, Krishnan, Usha, Ooi, Chee Y, Yap, Jason, Sharma, Ajay, and Day, Andrew S
- Subjects
- *
COVID-19 pandemic , *CELIAC disease , *DIAGNOSIS , *PEDIATRIC gastroenterology , *PEDIATRICS , *GASTROENTEROLOGISTS , *AUSTRALASIANS - Abstract
Aim: To explore the perceptions and practices of Australasian paediatric gastroenterologists in diagnosing coeliac disease (CD) before and during the COVID‐19 pandemic. Methods: Paediatric gastroenterologists in Australasia were invited via email to complete an anonymous online questionnaire over a 2‐week period in 2021. Results: The questionnaire was completed by 39 respondents: 33 from Australia and six from New Zealand (NZ) equating to a 66% response rate. Thirty‐four (87%) of the 39 respondents reported they currently practised non‐biopsy diagnosis of CD in eligible children, while the rest diagnosed CD using biopsy confirmation only. All NZ respondents practised non‐biopsy CD diagnosis. A majority of responders (76%) who practised non‐biopsy CD diagnosis followed the 2020 European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) guidelines. Twenty‐two (56%) respondents reported that they started using a non‐biopsy CD diagnosis protocol before the pandemic and did not change their practice during the pandemic, 10 (26%) started diagnosing non‐biopsy CD during the pandemic, 5 (13%) stated their practices of CD were not impacted by the pandemic and 2 (5%) did not respond on whether the pandemic changed their practice. Conclusion: The majority of Australasian gastroenterologist respondents reported they routinely utilised the 2020 ESPGHAN diagnostic criteria in eligible children; half of them started prior to the pandemic and another quarter started this approach due to the pandemic. A minority of practitioners routinely rely only on biopsy confirmation to diagnose CD. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
205. Physicians perceive that ostomates have decreased quality of life but not overall health: An international survey of physicians.
- Author
-
Eid, Mark A., Goldwag, Jenaya L., Gray, Philip P., Shaw, Robert D., and Ivatury, Srinivas J.
- Subjects
- *
PHYSICIANS' attitudes , *OSTOMATES , *GASTROENTEROLOGISTS , *WORLD health , *PHYSICIANS , *HEALTH surveys - Abstract
Aim: The aim of this work was to evaluate physicians' perceptions of ostomates' quality of life (QoL) and comfort of care among an international sample of physicians caring for ostomates. Method: This was a cross‐sectional survey study. We conducted a survey of primary care physicians (PCP), gastroenterologists (GI), and general surgeons (GS) from three continents using the SERMO online physician platform. We piloted the survey for content, clarity and domain development using a pilot sample of physicians from each speciality before use. We summarized responses to questions related to physician comfort of ostomate care with descriptive statistics. We conducted multiple logistic regression with the primary outcome of physician perception of ostomate QoL. Results: A total of 617 physicians (PCP 264, GI 176, GS 177) completed the survey representing North America, Europe and Australia similarly. The average age was 46 years and 21% were women. Ninety per cent of physicians care for an ostomate at least once per month. Eighty eight per cent had access to enterostomal nurses. Eighty two per cent of physicians believed that ostomates have decreased QoL. Forty seven per cent believed that ostomates have decreased overall health. Almost half of respondents answered incorrectly to a 'bogus question' citing fake clinical evidence supporting a negative impact of ostomies on social relationships. Increased physician comfort in ostomy care (OR 1.30, p = 0.04) and US‐based physicians (OR 1.75, p = 0.01) were associated with increased odds of answering that ostomates have no decreased QoL. Conclusion: Among a diverse international sample, most physicians believe that ostomates have decreased QoL but not overall health. Physician implicit bias, physician comfort and geographical variability account for these findings. Targeted efforts to increase physician comfort in ostomate care and establish universal best practices is needed. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
206. Switching from originator infliximab to biosimilar versus continuing on originator in inflammatory bowel disease: results from the observational Project NORTH study.
- Author
-
Hellström, Per M., Gemmen, Eric, Ward, Heather A., Koo, Hyewon, Faccin, Freddy, Xue, Zhenyi, and Malmborg, Petter
- Subjects
- *
INFLAMMATORY bowel diseases , *INFLIXIMAB , *ELECTRONIC health records , *TERMINATION of treatment , *CROHN'S disease , *GASTROENTEROLOGISTS , *MEDICAL care costs - Abstract
Project NORTH compared real-world clinical and economic outcomes in Swedish patients with inflammatory bowel disease (IBD) who switched from originator infliximab to its biosimilar. Data from electronic medical records and Swedish national registries were linked. Switchers (patients switching from originator infliximab to its biosimilar between 1 April 2014, and 31 December 2017) and non-switchers (patients who received originator infliximab and did not switch to a biosimilar by 31 December 2017) were followed up until 31 October 2019. Baseline concomitant medication use, disease duration, and inflammatory markers were lower among switchers than non-switchers. At 6 months, the proportion of patients with stable disease was higher among switchers than non-switchers (71/109 [65%] vs 54/107 [50%]; p =.0385); differences were not significant in subsequent follow-ups. At 6 and 24 months, 98% and 93% of switchers, respectively, used concomitant medications versus 96% and 79% of non-switchers. Throughout the study, all-cause treatment discontinuation occurred in 74 (67%) switchers and 105 (95%) non-switchers. At 36-months, mean (SD) number of IBD-related in-patient care days was higher among non-switchers (2.95 [4.71]) than switchers (1.40 [4.20]), as were total medical costs (€16,740 vs €3,872). No substantial differences in clinical outcomes or healthcare resource utilization were observed between switchers and non-switchers. Several analyses indicate that non-switchers might have more poorly controlled/severe disease than switchers at baseline. Overall, numerous difficulties might arise when executing a high-quality, real-world study, including possible selection bias for patients with better disease control for NMS, limiting the generalizability of the results. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
207. Evaluation of a Multidisciplinary Integrated Treatment Approach Versus Standard Model of Care for Functional Gastrointestinal Disorders (FGIDS): A Matched Cohort Study.
- Author
-
Bray, Nicola A., Koloski, Natasha A., Jones, Michael P., Do, Anh, Pang, Siong, Coombes, Jeff S., McAllister, Sarah, Campos, Jane, Arthur, Leela, Stanley, Paul, DeMaria, Katherine, Chao, Che-yung, Catague, Rachel, Whaley, Amanda, Talley, Nicholas J., and Holtmann, Gerald J.
- Subjects
- *
GASTROENTEROLOGISTS , *MEDICAL care standards , *COHORT analysis , *TERTIARY care , *MEDICAL care , *HEALTH care teams - Abstract
Background: Functional gastrointestinal disorders (FGID) are linked to a variety of potential causes, and treatments include reassurance, life-style (including diet), psychological, or pharmacologic interventions. Aims: To assess whether a multidisciplinary integrated treatment approach delivered in a dedicated integrated care clinic (ICC) was superior to the standard model of care in relation to the gastrointestinal symptom burden. Methods: A matched cohort of 52 consecutive patients with severe manifestation of FGID were matched with 104 control patients based upon diagnosis, gender, age, and symptom severity. Patients in the ICC received structured assessment and 12-weeks integrated treatment sessions provided as required by gastroenterologist and allied health team. Control patients received standard medical care at the same tertiary center with access to allied health services as required but no standardized interprofessional team approach. Primary outcome was reduction in gastrointestinal symptom burden as measured by the Structured Assessment of Gastrointestinal Symptoms Scale (SAGIS). Secondary outcome was reduction in anxiety and depressive symptoms as measured by the Hospital Anxiety and Depression Scale (HADS). Results: Mixed models estimated the within ICC change in SAGIS total as −9.7 (95% CI −13.6, −5.8; p < 0.0001), compared with −1.7 (95% CI −4.0, 0.6; p = 0.15) for controls. The difference between groups reached statistical significance, −7.6 (95% CI −11.4, −3.8; p < 0.0001). Total HADS scores in ICC patients were 3.4 points lower post-intervention and reached statistical significance (p = 0.001). Conclusion: This matched cohort study demonstrates superior short-term outcomes of FGID patients in a structured multidisciplinary care setting as compared to standard care. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
208. SDDF Abstracts 2022.
- Subjects
- *
DIGESTIVE system diseases , *CONFERENCES & conventions , *GASTROENTEROLOGISTS - Published
- 2022
- Full Text
- View/download PDF
209. Changes in Medicare Reimbursement for Common Gastroenterology Services Over 15 Years: 2007–2022.
- Author
-
Khunte, Mihir, Dang, Nhu, Zhong, Anthony, Kumar, Soryan, Kamp, Kendra, and Shah, Samir A.
- Subjects
- *
MEDICARE reimbursement , *MEDICAL fees , *GASTROENTEROLOGY , *OFFICES , *GASTROENTEROLOGISTS , *REIMBURSEMENT , *MEDICARE - Abstract
INTRODUCTION: We evaluated trends in Medicare reimbursement for common gastrointestinal (GI) services from 2007 to 2022. METHODS: Top GI procedures and office/inpatient visits were identified. The Physician Fee Schedule Look-Up Tool from Centers for Medicare & Medicaid Services was queried to extract reimbursement data. Reimbursement trends were analyzed, accounting for inflation. RESULTS: GI procedures exhibited an average decrease in unadjusted and adjusted reimbursement of 7.0% and 33.0%, respectively. Reimbursement for patient visits exhibited an inflation-adjusted decrease of 4.9%. DISCUSSION: The analysis revealed a steady decline in adjusted reimbursement for both GI procedures and patient visits in the past 15 years. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
210. Diversity, Equity, and Inclusion in Gastroenterology and Hepatology: A Survey of Where We Stand.
- Author
-
Rahal, Harman K., Tabibian, James H., Issaka, Rachel, Quezada, Sandra, Gray II, Darrell, Balzora, Sophie, Yang, Liu, Badiee, Jayraan, and May, Folasade
- Subjects
- *
CULTURAL pluralism , *DIVERSITY in the workplace , *HEPATOLOGY , *HEALTH equity , *VOCATIONAL guidance , *GASTROENTEROLOGISTS - Abstract
INTRODUCTION: In the setting of increasing attention to representation in medicine, we aimed to assess current perspectives of racial and ethnic workforce diversity and health care disparities among gastroenterology (GI) and hepatology professionals in the United States. METHODS: We developed and administered a 33-item electronic cross-sectional survey to members of 5 national GI and hepatology societies. Survey items were organized into thematic modules and solicited perspectives on racial and ethnic workforce diversity, health care disparities in GI and hepatology, and potential interventions to enhance workforce diversity and improve health equity. RESULTS: Of the 1,219 survey participants, 62.3% were male, 48.7% were non-Hispanic White, and 19.9% were from backgrounds underrepresented in medicine. The most frequently reported barriers to increasing racial and ethnic diversity in GI and hepatology were insufficient representation of underrepresented racial and ethnic minority groups in the education and training pipeline (n = 431 [35.4%]), in professional leadership (n = 340 [27.9%]), and among practicing GI and hepatology professionals (n = 324 [26.6%]). Suggested interventions were to increase career mentorship opportunities (n = 545 [44.7%]), medical student opportunities (n = 520 [42.7%]), and program and professional society leadership roles for underrepresented racial and ethnic minority groups (n = 473 [38.8%]). DISCUSSION: Our survey explored imperative and timely perspectives on racial and ethnic representation and health equity among professionals in GI and hepatology. The findings should inform future interventions to address workforce diversity and establish priorities toward improving health equity, ultimately serving as a springboard for professional societies, academic institutions, and other organizations that aim to increase diversity, equity, and inclusion in our field. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
211. REAP‐HP survey 2020: Comparing the real‐world practice and expectation in Helicobacter pylori eradication of the Taiwanese gastroenterologists in 2015 and 2020.
- Author
-
Chuah, Yoen‐Young, Wu, Deng‐Chyang, Chuah, Seng‐Kee, Chen, Kuan‐Yang, Yang, Jyh‐Chin, Lee, Chia‐Long, Chen, Chien‐Lin, Shiu, Sz‐Iuan, Shie, Chang‐Bih, Shih, Chih‐An, Tsay, Feng‐Woei, Liu, Yu‐Hwa, and Hsu, Ping‐I
- Subjects
- *
HELICOBACTER pylori , *GASTROENTEROLOGISTS , *CONFIDENCE intervals , *PHYSICIANS - Abstract
Background: REAP‐HP study (Real‐world practice and Expectation of Asia‐Pacific physicians and patients in Helicobacter Pylori eradication) was the pioneer study investigating the expectation and preference of physicians across Asia‐Pacific in H. pylori eradication in 2015. This study is the first follow‐up study of REAP‐HP in Taiwan. Aims: (1) To investigate the preference in regimens for the first‐line anti‐H. pylori therapy of Taiwanese gastroenterologist in 2020, (2) To survey the factor that cause the most concern when prescribing anti‐H. pylori regimens in clinical practice, and (3) to compare REAP‐HP survey data in 2020 and those surveyed in 2015 regarding the abovementioned end‐points. Methods: A questionnaire for H. pylori eradication survey of physicians was distributed to the gastroenterologists who attended the Taiwan Digestive Disease Week 2020. Data of most commonly used first‐line anti‐H. pylori regimens and concerned factors when prescribing anti‐H. pylori regimens between 2015 and 2020 were compared. Results: A total of 258 physicians from different districts of Taiwan participated in the REAP‐HP Survey in 2020. The top three most commonly used anti‐H. pylori regimens in Taiwan in 2020 were 14‐day standard triple therapy (36.8%; 95% confidence interval [CI]: 30.9%–42.7%), 7‐day standard triple therapy (17.8%; 95% CI: 13.1%–22.5%) and 14‐day reverse hybrid therapy (14.7%; 95% CI: 10.4%–19.0%) respectively. The top two factors that cause the most concern during prescribing anti‐H. pylori therapy were eradication rate (82.3%; 95% CI: 77.6%–87.0%) and side effect (10.4%; 95% CI: 6.7%–15.1%). In 2015, the top three most commonly used regimens in Taiwan were 7‐day standard triple therapy (62%; 95% CI: 56.2%–67.8%), 14‐day standard triple therapy (21%; 95% CI: 16.1%–25.9%) and 10‐day sequential therapy (7%; 95% CI: 4%–10%). A remarkable difference of the most commonly used anti‐H. pylori regimens between 2015 and 2020 existed (p <.001). The top two factors that cause the most concern during prescribing anti‐H. pylori therapy in 2015 were eradication rate (84.1%) and side effect (7.0%). There were no differences in the factors that cause the most concern during prescribing anti‐H. pylori regimens between 2015 and 2020. Conclusion: 14‐day standard triple therapy has replaced 7‐day standard triple therapy as the most commonly used first‐line anti‐H. pylori therapy among Taiwanese gastroenterologists in 2020. 14‐day reverse hybrid therapy is on rise to the third place as the most commonly used anti‐H. pylori regimen in Taiwan. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
212. The diagnosis and management of CMV colitis in IBD patients shows high practice variation: a national survey among gastroenterologists.
- Author
-
Goetgebuer, R. L., van der Woude, C. J., Bakker, L., van der Eijk, A. A., de Ridder, L., and de Vries, A. C.
- Subjects
- *
COLITIS , *INFLAMMATORY bowel diseases , *GASTROENTEROLOGISTS , *CYTOMEGALOVIRUS diseases , *VISUAL analog scale - Abstract
Clinical guidelines on cytomegalovirus (CMV) colitis in inflammatory bowel disease (IBD) are hampered by the low quality of evidence. In this study, we aim to explore the attitude and management of CMV colitis in IBD among gastroenterologists. A web-based survey was distributed to adult and pediatric gastroenterologists and trainees in academic and general hospitals in the Netherlands. The survey comprised data collection on respondents' demographics, attitudes towards the importance of CMV infection in IBD on a visual analogue scale (from 0 to 100), and diagnostic and therapeutic strategies. A total of 73/131 invited respondents from 32 hospitals completed the survey (response rate of 56%). The importance of CMV infection was scored at a median 74/100. Respondents indicated CMV testing as appropriate in the clinical setting of steroid-refractory colitis (69% of respondents), hospitalized patients with active colitis (64%), immunomodulator or biological refractory colitis (55%) and active colitis irrespective of medication use (14%). CMV diagnostics include histology of colonic biopsies (88% of respondents), tissue CMV PCR (43%), serum CMV PCR (60%), CMV serology (25%) and fecal CMV PCR (4%). 82% of respondents start antiviral therapy after a positive CMV test on colonic biopsies (histology or PCR). Most Dutch gastroenterologists acknowledge the importance of CMV colitis in IBD. Strategies vary greatly with regard to the indication for testing and diagnostic method, as well as indication for the start of antiviral therapy. These findings underline the need for pragmatic clinical studies on different management strategies, in order to reduce practice variation and improve the quality of care. The clinical significance of CMV-associated colitis in IBD remains a matter of debate Recommendations regarding CMV colitis in current international guidelines are based on low to moderate evidence levels and different diagnostic strategies are proposed We show that there is a high practice variation of diagnosis and management of CMV colitis in IBD amongst adult and pediatric gastroenterologists This study underlined the need for pragmatic studies and guidelines on different management strategies including cut-off values to start therapy [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
213. Quality Indicators for Capsule Endoscopy and Deep Enteroscopy.
- Author
-
Leighton, Jonathan A., Brock, Andrew S., Semrad, Carol E., Hass, David J., Guda, Nalini M., Barkin, Jodie A., and Eisen, Glenn M.
- Subjects
- *
CAPSULE endoscopy , *ENTEROSCOPY , *TASK forces , *SMALL intestine , *GASTROENTEROLOGISTS , *INTESTINAL diseases - Abstract
INTRODUCTION: Capsule endoscopy (CE) and deep enteroscopy (DE) can be useful for diagnosing and treating suspected small-bowel disease. Guidelines and detailed recommendations exist for the use of CE/DE, but comprehensive quality indicators are lacking. The goal of this task force was to develop quality indicators for appropriate use of CE/DE by using a modified RAND/UCLA Appropriateness Method. METHODS: An expert panel of 7 gastroenterologists with diverse practice experience was assembled to identify quality indicators. A literature review was conducted to develop a list of proposed quality indicators applicable to preprocedure, intraprocedure, and postprocedure periods. The panelists reviewed the literature; identified and modified proposed quality indicators; rated them on the basis of scientific evidence, validity, and necessity; and determined proposed performance targets. Agreement and consensus with the proposed indicators were verified using the RAND/UCLA Appropriateness Method. RESULTS: The voting procedure to prioritize metrics emphasized selecting measures to improve quality and overall patient care. Panelists rated indicators on the perceived appropriateness and necessity for clinical practice. After voting and discussion, 2 quality indicators ranked as inappropriate or uncertain were excluded. Each quality indicator was categorized by measure type, performance target, and summary of evidence. The task force identified 13 quality indicators for CE and DE. DISCUSSION: Comprehensive quality indicators have not existed for CE or DE. The task force identified quality indicators that can be incorporated into clinical practice. The panel also addressed existing knowledge gaps and posed research questions to better inform future research and quality guidelines for these procedures. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
214. How to Infuse Joy in Your Practice: Our Journey to Sustainable Well-Being.
- Author
-
Stonnington, Cynthia M., Jones, Keith, and Leighton, Jonathan A.
- Subjects
- *
WELL-being , *JOY , *SELF-determination theory , *MASLACH Burnout Inventory , *MEDICAL personnel , *GASTROENTEROLOGISTS , *LEADERSHIP - Abstract
Burnout, characterized by emotional fatigue, cynical detachment toward patients, and a feeling of reduced personal accomplishment ([4]), is highly prevalent among physicians and medical staff ([2]), and up to 50% of gastroenterologists ([[2], [5]]). This paper offers a case study on how medical practices, large and small, can infuse daily joy and well-being in the workplace, so physicians and their care teams remain resilient and fulfilled while providing effective and benevolent care to patients. Three-year-old Vada, who dreamed about being a princess, was wearing a sparkly dress and unicorn headband where her hair used to be. 2016; 31:, 1004-10. 3 Shanafelt T,, Trockel M,, Rodriguez A,, Logan D. Wellness-centered leadership: Equipping health care leaders to cultivate physician well-being and professional fulfillment. [Extracted from the article]
- Published
- 2022
- Full Text
- View/download PDF
215. Impact of Proceduralist Specialty on Outcomes Following Endoscopic Sleeve Gastroplasty.
- Author
-
Gudur, Anuragh R., Geng, Calvin, Hallowell, Peter, Schirmer, Bruce, Shami, Vanessa M., Wang, Andrew Y., and Podboy, Alexander
- Subjects
GASTRIC bypass ,SLEEVE gastrectomy ,BARIATRIC surgery ,WEIGHT loss ,GASTROENTEROLOGISTS ,GASTRIC banding ,HOSPITAL emergency services - Abstract
Purpose: Endoscopic sleeve gastroplasty (ESG) is a novel minimally invasive weight loss procedure designed to mimic gastric volume reduction of surgical sleeve gastrectomy. Currently, both bariatric surgeons and gastroenterologists perform ESG, and early reports suggest that ESG is safe and effective for weight loss. However, as gastroenterologists and bariatric surgeons have variations in training backgrounds, it is important to evaluate for potential differences in clinical outcomes. To date, there are no studies comparing the impact of proceduralist specialization on outcomes of ESG. This study aims to assess whether proceduralist specialization impacts short-term safety and efficacy after ESG. Methods: We retrospectively analyzed over 6,000 patients who underwent ESG from 2016 to 2020 in the Metabolic and Bariatric Surgery Accreditation and Quality Improvement Program (MBSAQIP) database. ESG patients were stratified into two groups depending on the specialty of the physician performing the procedure, and propensity matched using baseline patient characteristics. We primarily compared adverse events (AE), readmissions, re-operations, and re-interventions within 30 days after procedure. Secondary outcomes included procedure time, length of stay (LOS), early weight loss, and emergency department (ED) visits after procedure. Results: There was no difference in AE in ESG performed by gastroenterologists and bariatric surgeons. ESG performed by bariatric surgeons demonstrated a trend towards higher rate of re-operations within 30 days. ESG performed by gastroenterologists had more ED visits but did not lead to higher rate of re-intervention. LOS was shorter in ESG performed by gastroenterologists, but procedure time was longer. Conclusions: ESG is safely performed by both gastroenterologists and bariatric surgeons. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
216. Artificial intelligence in (gastrointestinal) healthcare: patients' and physicians' perspectives.
- Author
-
van der Zander, Quirine E. W., van der Ende - van Loon, Mirjam C. M., Janssen, Janneke M. M., Winkens, Bjorn, van der Sommen, Fons, Masclee, Ad. A. M., and Schoon, Erik J.
- Subjects
- *
PHYSICIANS' attitudes , *ARTIFICIAL intelligence , *MEDICAL care , *GASTROENTEROLOGISTS , *PHYSICIAN services utilization - Abstract
Artificial intelligence (AI) is entering into daily life and has the potential to play a significant role in healthcare. Aim was to investigate the perspectives (knowledge, experience, and opinion) on AI in healthcare among patients with gastrointestinal (GI) disorders, gastroenterologists, and GI-fellows. In this prospective questionnaire study 377 GI-patients, 35 gastroenterologists, and 45 GI-fellows participated. Of GI-patients, 62.5% reported to be familiar with AI and 25.0% of GI-physicians had work-related experience with AI. GI-patients preferred their physicians to use AI (mean 3.9) and GI-physicians were willing to use AI (mean 4.4, on 5-point Likert-scale). More GI-physicians believed in an increase in quality of care (81.3%) than GI-patients (64.9%, χ2(2) = 8.2, p = 0.017). GI-fellows expected AI implementation within 6.0 years, gastroenterologists within 4.2 years (t(76) = − 2.6, p = 0.011), and GI-patients within 6.1 years (t(193) = − 2.0, p = 0.047). GI-patients and GI-physicians agreed on the most important advantages of AI in healthcare: improving quality of care, time saving, and faster diagnostics and shorter waiting times. The most important disadvantage for GI-patients was the potential loss of personal contact, for GI-physicians this was insufficiently developed IT infrastructures. GI-patients and GI-physicians hold positive perspectives towards AI in healthcare. Patients were significantly more reserved compared to GI-fellows and GI-fellows were more reserved compared to gastroenterologists. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
217. Clinical features of very early-onset inflammatory bowel disease in Japan: a retrospective single-center study.
- Author
-
Masaaki Usami, Ichiro Takeuchi, Reiko Kyodo, Yuri Hirano, Kosuke Kashiwagi, Hiroki Fujikawa, Hirotaka Shimizu, Toshinao Kawai, and Katsuhiro Arai
- Subjects
- *
INFLAMMATORY bowel diseases , *GASTROENTEROLOGISTS , *PEDIATRICS - Abstract
Background/Aims: Very early-onset inflammatory bowel disease (VEO-IBD), defined as IBD diagnosed in patients younger than 6 years, is a challenge for pediatric gastroenterologists. Although there have been reports regarding VEO-IBD in Western countries, those in Asia are still lacking. This study aimed to investigate the clinical features of Japanese VEO-IBD patients. Methods: Patients with VEO-IBD diagnosed between 2006 and 2019 were evaluated retrospectively. The disease phenotypes were classified into ulcerative colitis type (UC-type) and Crohn's disease type (CD-type), and the clinical features and courses were compared between the phenotypes. Results: Overall, 54 VEO-IBD patients (19 patients with UC-type and 35 patients with CD-type) were evaluated. The median age at onset was 18 months. One patient had severe combined immunodeficiency (SCID), and 9 patients had monogenic IBD. Monogenic IBD was more prevalent in the CD-type patients with perianal disease (CD-type (PD)). The age at onset was significantly lower in the CD-type group (P< 0.05). The most common initial symptom was bloody stools (70%), followed by diarrhea (63%), weight loss (24%), fever (20%), and perianal disease (20%). Excluding patients with SCID and monogenic IBD, 23 out of 44 patients (52%) required biologics. The biologics were switched in 11 out of 44 patients (25%), and the majority of these patients (82%) were in the CD-type group. Overall, 9 patients (20%) required intestinal resection or ostomy placement. Conclusions: CD-type tends to occur at an earlier age, and monogenic IBD occurs significantly more frequently in CD-type (PD). Disease severity and treatment should be individualized, owing to the disease heterogeneity. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
218. Gender, Race, and Ethnicity Representation Among Gastroenterologists: A Review of Recent Trends.
- Author
-
Rahal, Harman, Girotra, Mohit, May, Folasade P., and Tabibian, James H.
- Subjects
- *
RACE , *CULTURAL pluralism , *MEDICAL quality control , *GASTROENTEROLOGISTS , *MOBILE geographic information systems , *GENDER , *INTERNISTS - Abstract
Diversity in medicine and the gastroenterology (GI) subspecialty is a topic warranting attention, especially in light of a number of recent incidents highlighting the persistence of racial, ethnic, and gender injustice in our nation. Insight into this topic is important insofar as the multitude of racial, ethnic, and gender backgrounds comprising the national patient population should be reflected, to the degree possible, by the providers serving it. Inclusion becomes particularly imperative because the quality of health care and health research and bridging disparities may be closely linked to adequate representation among healthcare providers. Despite the urgency of this topic, there is a paucity of data examining trends in gender and racial/ethnic diversity among medical professionals within the field of GI. In this narrative review, we examine how ethnoracial and gender representation has changed over time at critical points along the educational, training, and career pathways in GI. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
219. Clinical utility of thiopurine metabolite monitoring in inflammatory bowel disease and its impact on healthcare utilization in Singapore.
- Author
-
Yeo, Jia Qi, Cheen, Hua Heng McVin, Wong, Amanda, Lim, Teong Guan, Chowbay, Balram, Leong, Wai Fook, Wang, Chunyan, Salazar, Ennaliza, Chan, Webber Pak Wo, Kong, San Choon, and Ong, Wan Chee
- Subjects
INFLAMMATORY bowel diseases ,CROHN'S disease ,ULCERATIVE colitis ,MEDICAL care costs ,MEDICAL care ,GASTROENTEROLOGISTS - Abstract
Background and Aim: Thiopurines are recommended for maintenance of steroid‐free remission (SFR) in inflammatory bowel disease (IBD). Thiopurine metabolite monitoring (MM) is increasingly used in the West but remains novel in Singapore, with limited information on its therapeutic and economic benefits. Hence, this study aims to investigate MM's clinical utility and its impact on healthcare resource utilization in Singaporean IBD patients. Methods: A retrospective observational study was conducted at Singapore General Hospital outpatient IBD Centre. Patients with IBD, baseline MM during 2014–2017, and weight‐based thiopurine doses for ≥4 weeks were followed up for 1 year. Actions were taken to optimize therapy, and metabolite levels before and after the first action were documented. Outcomes assessed included SFR, no therapy escalation or surgery, healthcare resource utilization, and direct healthcare costs. Results: Ninety IBD patients (50 Crohn's disease, 40 ulcerative colitis) were included. Among them, 40% had baseline metabolite levels within therapeutic range, 31.1% sub‐therapeutic, 21.1% supra‐therapeutic, and 7.8% shunters. Repeated MM with subsequent dose optimization helped 67.2% of patients achieve therapeutic levels after 1 year. Overall, 87.8% of patients achieved SFR and 90% had no therapy escalation or surgery. Despite greater outpatient visits and laboratory investigations with MM, the median total healthcare costs at 1 year only increased marginally (S$6407.66 [shunters] vs S$5215.20 [supra‐therapeutic] vs S$4970.80 [sub‐therapeutic] vs S$4370.48 [control (within therapeutic range)], P = 0.592). Conclusion: MM guided timely therapy escalation for non‐responders, identification of non‐adherence, and reversal of shunting. Therefore, it is a useful clinical tool to optimize thiopurines without significantly increasing healthcare costs. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
220. Climate change: a survey of global gastroenterology society leadership.
- Author
-
Leddin, Desmond, Omary, M. Bishr, Metz, Geoffrey, and Veitch, Andrew M.
- Subjects
CLIMATE change ,LEADERSHIP ,GASTROENTEROLOGY ,GASTROENTEROLOGISTS ,CLIMATE change & health ,ATMOSPHERIC carbon dioxide - Published
- 2022
- Full Text
- View/download PDF
221. Patched but Still Leaky: An Update on the Pipeline for Women in Gastroenterology.
- Author
-
Sharma, Nivita D., Young, Karen C., Feld, Lauren D., and Rabinowitz, Loren G.
- Subjects
- *
WOMEN physicians , *GENDER inequality , *GASTROENTEROLOGISTS , *INTERNAL medicine , *MENTORING - Abstract
Background: Women remain underrepresented in gastroenterology (GI). Studies have identified that a lack of formal mentorship for women contributes to this underrepresentation. While many GI divisions have adopted models for supporting GI fellows and faculty, there is a gap in our knowledge regarding mentorship options for internal medicine (IM) residents interested in GI.To evaluate representation of women at each level of their career (resident, fellow, and attending) and examine trends in representation of women in GI compared to other IM subspecialties.We analyzed AAMC Physician Specialty Data Reports to compare gender representation and growth of women representation across all IM subspecialties and residencies from 2007 to 2021.In 2021, 44.3% of IM residents, 37.8% of GI fellows, and 19.7% of actively practicing attending gastroenterologists were women. Since 2007, GI comprised significantly lower proportions of women attendings except for cardiology, and lower representation in fellows, except for cardiology and nephrology, than other IM subspecialties (
p < 0.001). There was a consistently higher proportion of women GI fellows than attendings over the past 14 years (p < 0.01).GI has among the lowest representation of women at each career level compared to other IM subspecialties. Given the previously reported preference of gender congruent mentoring, the underrepresentation of senior academic gastroenterologists who are women may be a contributing factor to lower proportions of women trainees choosing to pursue GI.Aims: Women remain underrepresented in gastroenterology (GI). Studies have identified that a lack of formal mentorship for women contributes to this underrepresentation. While many GI divisions have adopted models for supporting GI fellows and faculty, there is a gap in our knowledge regarding mentorship options for internal medicine (IM) residents interested in GI.To evaluate representation of women at each level of their career (resident, fellow, and attending) and examine trends in representation of women in GI compared to other IM subspecialties.We analyzed AAMC Physician Specialty Data Reports to compare gender representation and growth of women representation across all IM subspecialties and residencies from 2007 to 2021.In 2021, 44.3% of IM residents, 37.8% of GI fellows, and 19.7% of actively practicing attending gastroenterologists were women. Since 2007, GI comprised significantly lower proportions of women attendings except for cardiology, and lower representation in fellows, except for cardiology and nephrology, than other IM subspecialties (p < 0.001). There was a consistently higher proportion of women GI fellows than attendings over the past 14 years (p < 0.01).GI has among the lowest representation of women at each career level compared to other IM subspecialties. Given the previously reported preference of gender congruent mentoring, the underrepresentation of senior academic gastroenterologists who are women may be a contributing factor to lower proportions of women trainees choosing to pursue GI.Methods: Women remain underrepresented in gastroenterology (GI). Studies have identified that a lack of formal mentorship for women contributes to this underrepresentation. While many GI divisions have adopted models for supporting GI fellows and faculty, there is a gap in our knowledge regarding mentorship options for internal medicine (IM) residents interested in GI.To evaluate representation of women at each level of their career (resident, fellow, and attending) and examine trends in representation of women in GI compared to other IM subspecialties.We analyzed AAMC Physician Specialty Data Reports to compare gender representation and growth of women representation across all IM subspecialties and residencies from 2007 to 2021.In 2021, 44.3% of IM residents, 37.8% of GI fellows, and 19.7% of actively practicing attending gastroenterologists were women. Since 2007, GI comprised significantly lower proportions of women attendings except for cardiology, and lower representation in fellows, except for cardiology and nephrology, than other IM subspecialties (p < 0.001). There was a consistently higher proportion of women GI fellows than attendings over the past 14 years (p < 0.01).GI has among the lowest representation of women at each career level compared to other IM subspecialties. Given the previously reported preference of gender congruent mentoring, the underrepresentation of senior academic gastroenterologists who are women may be a contributing factor to lower proportions of women trainees choosing to pursue GI.Results: Women remain underrepresented in gastroenterology (GI). Studies have identified that a lack of formal mentorship for women contributes to this underrepresentation. While many GI divisions have adopted models for supporting GI fellows and faculty, there is a gap in our knowledge regarding mentorship options for internal medicine (IM) residents interested in GI.To evaluate representation of women at each level of their career (resident, fellow, and attending) and examine trends in representation of women in GI compared to other IM subspecialties.We analyzed AAMC Physician Specialty Data Reports to compare gender representation and growth of women representation across all IM subspecialties and residencies from 2007 to 2021.In 2021, 44.3% of IM residents, 37.8% of GI fellows, and 19.7% of actively practicing attending gastroenterologists were women. Since 2007, GI comprised significantly lower proportions of women attendings except for cardiology, and lower representation in fellows, except for cardiology and nephrology, than other IM subspecialties (p < 0.001). There was a consistently higher proportion of women GI fellows than attendings over the past 14 years (p < 0.01).GI has among the lowest representation of women at each career level compared to other IM subspecialties. Given the previously reported preference of gender congruent mentoring, the underrepresentation of senior academic gastroenterologists who are women may be a contributing factor to lower proportions of women trainees choosing to pursue GI.Conclusions: Women remain underrepresented in gastroenterology (GI). Studies have identified that a lack of formal mentorship for women contributes to this underrepresentation. While many GI divisions have adopted models for supporting GI fellows and faculty, there is a gap in our knowledge regarding mentorship options for internal medicine (IM) residents interested in GI.To evaluate representation of women at each level of their career (resident, fellow, and attending) and examine trends in representation of women in GI compared to other IM subspecialties.We analyzed AAMC Physician Specialty Data Reports to compare gender representation and growth of women representation across all IM subspecialties and residencies from 2007 to 2021.In 2021, 44.3% of IM residents, 37.8% of GI fellows, and 19.7% of actively practicing attending gastroenterologists were women. Since 2007, GI comprised significantly lower proportions of women attendings except for cardiology, and lower representation in fellows, except for cardiology and nephrology, than other IM subspecialties (p < 0.001). There was a consistently higher proportion of women GI fellows than attendings over the past 14 years (p < 0.01).GI has among the lowest representation of women at each career level compared to other IM subspecialties. Given the previously reported preference of gender congruent mentoring, the underrepresentation of senior academic gastroenterologists who are women may be a contributing factor to lower proportions of women trainees choosing to pursue GI. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
222. Assessment of Physician Needs and Access to Inflammatory Bowel Disease Specialty Care Resources in a National Integrated Health System.
- Author
-
Cohen-Mekelburg, Shirley, Johnson, Jessica, Paine, Elizabeth, Prasad, Meena A., Dominitz, Jason A., and Hou, Jason
- Subjects
- *
INFLAMMATORY bowel diseases , *GASTROENTEROLOGISTS , *VETERANS' health , *CROHN'S disease , *PHYSICIANS , *PRIMARY care - Abstract
Background: The barriers to providing high-quality inflammatory bowel disease (IBD) care go beyond educational needs alone to include access to IBD-related resources such as medications, laboratory testing, and multidisciplinary teams. We assessed the needs and resource constraints of physicians caring for Veterans with IBD to inform efforts to improve access to high-quality care.We conducted a national observational survey study in July 2021 of gastroenterologists (GIs) and primary care providers (PCPs) caring for Veterans with IBD within the Veterans Health Administration with the intent of including physicians from all 18 Veterans Integrated Service Networks (VISN). We reported descriptive statistics and compared responses between gastroenterologists (GIs) and primary care providers (PCPs), practice locations, and years of experience using
χ 2 tests.Overall, 173 of 2241 eligible physicians completed the survey, representing an individual physician response rate of 7.7% and VISN response rate of 18 out of 18 (100%). We identified several areas of IBD care where GIs and PCPs reported discomfort including medication prescribing, treatment strategies, and special populations. Further, variability in access to IBD services and awareness of the availability of IBD-targeted medications and laboratory tests was common. This survey also highlights the frequency with which PCPs were identified among the highest volume IBD providers in their facility.Variation in GIs’ and PCPs’ comfort with IBD treatment and access to IBD resources is common and needs to be considered in leveraging virtual care and educational programs and managing the expansion of IBD support and resources within VA.Methods: The barriers to providing high-quality inflammatory bowel disease (IBD) care go beyond educational needs alone to include access to IBD-related resources such as medications, laboratory testing, and multidisciplinary teams. We assessed the needs and resource constraints of physicians caring for Veterans with IBD to inform efforts to improve access to high-quality care.We conducted a national observational survey study in July 2021 of gastroenterologists (GIs) and primary care providers (PCPs) caring for Veterans with IBD within the Veterans Health Administration with the intent of including physicians from all 18 Veterans Integrated Service Networks (VISN). We reported descriptive statistics and compared responses between gastroenterologists (GIs) and primary care providers (PCPs), practice locations, and years of experience usingχ 2 tests.Overall, 173 of 2241 eligible physicians completed the survey, representing an individual physician response rate of 7.7% and VISN response rate of 18 out of 18 (100%). We identified several areas of IBD care where GIs and PCPs reported discomfort including medication prescribing, treatment strategies, and special populations. Further, variability in access to IBD services and awareness of the availability of IBD-targeted medications and laboratory tests was common. This survey also highlights the frequency with which PCPs were identified among the highest volume IBD providers in their facility.Variation in GIs’ and PCPs’ comfort with IBD treatment and access to IBD resources is common and needs to be considered in leveraging virtual care and educational programs and managing the expansion of IBD support and resources within VA.Results: The barriers to providing high-quality inflammatory bowel disease (IBD) care go beyond educational needs alone to include access to IBD-related resources such as medications, laboratory testing, and multidisciplinary teams. We assessed the needs and resource constraints of physicians caring for Veterans with IBD to inform efforts to improve access to high-quality care.We conducted a national observational survey study in July 2021 of gastroenterologists (GIs) and primary care providers (PCPs) caring for Veterans with IBD within the Veterans Health Administration with the intent of including physicians from all 18 Veterans Integrated Service Networks (VISN). We reported descriptive statistics and compared responses between gastroenterologists (GIs) and primary care providers (PCPs), practice locations, and years of experience usingχ 2 tests.Overall, 173 of 2241 eligible physicians completed the survey, representing an individual physician response rate of 7.7% and VISN response rate of 18 out of 18 (100%). We identified several areas of IBD care where GIs and PCPs reported discomfort including medication prescribing, treatment strategies, and special populations. Further, variability in access to IBD services and awareness of the availability of IBD-targeted medications and laboratory tests was common. This survey also highlights the frequency with which PCPs were identified among the highest volume IBD providers in their facility.Variation in GIs’ and PCPs’ comfort with IBD treatment and access to IBD resources is common and needs to be considered in leveraging virtual care and educational programs and managing the expansion of IBD support and resources within VA.Conclusions: The barriers to providing high-quality inflammatory bowel disease (IBD) care go beyond educational needs alone to include access to IBD-related resources such as medications, laboratory testing, and multidisciplinary teams. We assessed the needs and resource constraints of physicians caring for Veterans with IBD to inform efforts to improve access to high-quality care.We conducted a national observational survey study in July 2021 of gastroenterologists (GIs) and primary care providers (PCPs) caring for Veterans with IBD within the Veterans Health Administration with the intent of including physicians from all 18 Veterans Integrated Service Networks (VISN). We reported descriptive statistics and compared responses between gastroenterologists (GIs) and primary care providers (PCPs), practice locations, and years of experience usingχ 2 tests.Overall, 173 of 2241 eligible physicians completed the survey, representing an individual physician response rate of 7.7% and VISN response rate of 18 out of 18 (100%). We identified several areas of IBD care where GIs and PCPs reported discomfort including medication prescribing, treatment strategies, and special populations. Further, variability in access to IBD services and awareness of the availability of IBD-targeted medications and laboratory tests was common. This survey also highlights the frequency with which PCPs were identified among the highest volume IBD providers in their facility.Variation in GIs’ and PCPs’ comfort with IBD treatment and access to IBD resources is common and needs to be considered in leveraging virtual care and educational programs and managing the expansion of IBD support and resources within VA. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
223. Validation of Quality Assessment Measures for Inpatient Gastroenterology Consults on Oncologic Patients in Non-teaching Services at a Cancer Center: A Cross-Sectional Study.
- Author
-
Kidambi, Trilokesh D., Qadri, Rateeba, Varughese, Jay, Seto, Tyler, Idos, Gregory, Lin, James, Hirsch, Peter, Trieu, Harry, Ma, Huiyan, Hein, Marjorie, Ahn, Alice, Hy-Hincy, Claire, Lew, Michael W., Kessler, Jonathan, Perumpail, Ryan B., Terdiman, Jonathan P., Lee, Jeffrey K., Day, Lukejohn, Manesh, Reza Sedighi, and Taplitz, Randy
- Subjects
- *
SERVICES for cancer patients , *ELECTRONIC health records , *CROSS-sectional method , *SERVICE centers , *INTER-observer reliability , *ONCOLOGY nursing , *GASTROENTEROLOGISTS - Abstract
Objective: To develop and validate tools for measuring inpatient gastroenterology (GI) consultation quality on oncologic patients.A total of 145 inpatient GI consults were analyzed using electronic health records in this cross-sectional study. Essential Consult Elements on oncologic-hospitalized patients (EE-COH) and Hospitalized Oncologic Patients Enhanced Quality of Consult Assessment Tool (HOPE-QCAT) were used for grading. Interrater reliability was assessed.Both EE-COH and HOPE-QCAT showed near-perfect interrater reliability across most measures in the validation cohort. On application of these measures for quality assessment, basic evaluation by the requesting hospitalist was partially complete in 24.8%, the request for GI consultation was inappropriate in 18.6%, while the rationale for recommended studies from the GI consultant was provided in 55.7% of cases suggesting key areas for quality improvement.We developed highly reliable quality measures for inpatient GI consults on oncology patients. The EE-COH and HOPE-QCAT tools can be utilized in future studies of inpatient GI consult quality and to form the basis for interventions to improve communication between consultants and hospitalists. Such tools could be adapted for inpatient quality assessment across other specialties and settings.Methods: To develop and validate tools for measuring inpatient gastroenterology (GI) consultation quality on oncologic patients.A total of 145 inpatient GI consults were analyzed using electronic health records in this cross-sectional study. Essential Consult Elements on oncologic-hospitalized patients (EE-COH) and Hospitalized Oncologic Patients Enhanced Quality of Consult Assessment Tool (HOPE-QCAT) were used for grading. Interrater reliability was assessed.Both EE-COH and HOPE-QCAT showed near-perfect interrater reliability across most measures in the validation cohort. On application of these measures for quality assessment, basic evaluation by the requesting hospitalist was partially complete in 24.8%, the request for GI consultation was inappropriate in 18.6%, while the rationale for recommended studies from the GI consultant was provided in 55.7% of cases suggesting key areas for quality improvement.We developed highly reliable quality measures for inpatient GI consults on oncology patients. The EE-COH and HOPE-QCAT tools can be utilized in future studies of inpatient GI consult quality and to form the basis for interventions to improve communication between consultants and hospitalists. Such tools could be adapted for inpatient quality assessment across other specialties and settings.Results: To develop and validate tools for measuring inpatient gastroenterology (GI) consultation quality on oncologic patients.A total of 145 inpatient GI consults were analyzed using electronic health records in this cross-sectional study. Essential Consult Elements on oncologic-hospitalized patients (EE-COH) and Hospitalized Oncologic Patients Enhanced Quality of Consult Assessment Tool (HOPE-QCAT) were used for grading. Interrater reliability was assessed.Both EE-COH and HOPE-QCAT showed near-perfect interrater reliability across most measures in the validation cohort. On application of these measures for quality assessment, basic evaluation by the requesting hospitalist was partially complete in 24.8%, the request for GI consultation was inappropriate in 18.6%, while the rationale for recommended studies from the GI consultant was provided in 55.7% of cases suggesting key areas for quality improvement.We developed highly reliable quality measures for inpatient GI consults on oncology patients. The EE-COH and HOPE-QCAT tools can be utilized in future studies of inpatient GI consult quality and to form the basis for interventions to improve communication between consultants and hospitalists. Such tools could be adapted for inpatient quality assessment across other specialties and settings.Conclusion: To develop and validate tools for measuring inpatient gastroenterology (GI) consultation quality on oncologic patients.A total of 145 inpatient GI consults were analyzed using electronic health records in this cross-sectional study. Essential Consult Elements on oncologic-hospitalized patients (EE-COH) and Hospitalized Oncologic Patients Enhanced Quality of Consult Assessment Tool (HOPE-QCAT) were used for grading. Interrater reliability was assessed.Both EE-COH and HOPE-QCAT showed near-perfect interrater reliability across most measures in the validation cohort. On application of these measures for quality assessment, basic evaluation by the requesting hospitalist was partially complete in 24.8%, the request for GI consultation was inappropriate in 18.6%, while the rationale for recommended studies from the GI consultant was provided in 55.7% of cases suggesting key areas for quality improvement.We developed highly reliable quality measures for inpatient GI consults on oncology patients. The EE-COH and HOPE-QCAT tools can be utilized in future studies of inpatient GI consult quality and to form the basis for interventions to improve communication between consultants and hospitalists. Such tools could be adapted for inpatient quality assessment across other specialties and settings. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
224. Three AI Innovations Set to Revolutionize IBD Care.
- Subjects
GENERATIVE artificial intelligence ,DIFFUSION of innovations ,GASTROENTEROLOGY ,INFLAMMATORY bowel diseases ,GASTROENTEROLOGISTS - Abstract
The article focuses on how Artificial Intelligence (AI) is poised to transform the management of inflammatory bowel disease (IBD) in gastroenterology. Topics include AI's role in improving image analysis, natural language processing, and generative AI, the advancements in scoring systems for IBD severity, and AI's potential to enhance ulcer measurement and disease pattern recognition.
- Published
- 2024
225. Assessment of the spectrum of hepatic encephalopathy: A multicenter study
- Author
-
Reuter, Bradley, Walter, Kara, Bissonnette, Julien, Leise, Michael D, Lai, Jennifer, Tandon, Puneeta, Kamath, Patrick S, Biggins, Scott W, Rose, Christopher F, Wade, James B, and Bajaj, Jasmohan S
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Liver Disease ,Digestive Diseases ,Ammonia ,Biomarkers ,Canada ,Clinical Competence ,Cognition ,Diet ,Protein-Restricted ,Education ,Medical ,Graduate ,Gastroenterologists ,Gastroenterology ,Health Care Surveys ,Hepatic Encephalopathy ,Humans ,Liver Function Tests ,Neuropsychological Tests ,Nurse Practitioners ,Patient Simulation ,Physician Assistants ,Practice Patterns ,Nurses' ,Practice Patterns ,Physicians' ,Predictive Value of Tests ,Rifamycins ,Rifaximin ,Risk Factors ,Severity of Illness Index ,United States ,Video Recording ,Surgery ,Clinical sciences - Abstract
Hepatic encephalopathy (HE) is a major cause of morbidity in cirrhosis. However, its severity assessment is often subjective, which needs to be studied systematically. The aim was to determine how accurately trainee and nontrainee practitioners grade and manage HE patients throughout its severity. We performed a survey study using standardized simulated patient videos at 4 US and 3 Canadian centers. Participants were trainees (gastroenterology/hepatology fellows) and nontrainees (faculty, nurse practitioners, physician assistants). We determined the accuracy of HE severity identification and management options between grades 2. Serum ammonia levels were ordered in almost a third of grade ≥2 patients. For trainees and nontrainees, HE grades were identified similarly between groups. Trainees were less likely to order serum ammonia and low-protein diets, more likely to order rifaximin, and more likely to perform a more thorough workup for precipitating factors compared with nontrainee respondents. There was excellent concordance in the classification of grade ≥2 HE between nontrainees versus trainees, but lower grades showed discordance. Important differences were seen regarding blood ammonia, specialized testing, and nutritional management between trainees and nontrainees. These results have important implications at the patient level, interpreting multicenter clinical trials, and in the education of practitioners. Liver Transplantation 24 587-594 2018 AASLD.
- Published
- 2018
226. The Liver Frailty Index Improves Mortality Prediction of the Subjective Clinician Assessment in Patients With Cirrhosis
- Author
-
Lai, Jennifer C, Covinsky, Kenneth E, McCulloch, Charles E, and Feng, Sandy
- Subjects
Biomedical and Clinical Sciences ,Clinical Sciences ,Digestive Diseases ,Liver Disease ,Clinical Research ,Good Health and Well Being ,Clinical Decision-Making ,Female ,Frailty ,Gastroenterologists ,Hand Strength ,Humans ,Liver Cirrhosis ,Liver Transplantation ,Male ,Middle Aged ,Postural Balance ,Prognosis ,Proportional Hazards Models ,Waiting Lists ,Gastroenterology & Hepatology ,Clinical sciences - Abstract
ObjectivesFrailty, a critical determinant of health outcomes, is most commonly assessed in patients with cirrhosis by general clinician assessment that is limited by its subjectivity. We aimed to compare the objective Liver Frailty Index (LFI), consisting of three performance-based tests (grip, chair stands, balance), with a subjective hepatologist assessment.MethodsOutpatients with cirrhosis awaiting liver transplantation (LT) underwent: (1) objective measurement using the LFI and (2) subjective clinician assessment. Spearman's correlation assessed associations between the LFI and clinician assessment; Cox regression with waitlist mortality (death/delisting for sickness); discriminative ability with Concordance(C) statistics. The net reclassification index evaluated the percentage of patients correctly reclassified by adding the LFI to the clinician assessment.ResultsOf the 529 patients with cirrhosis, median LFI was 3.8 (range 1.0-7.0) and clinician assessment was 3 (range 0-5). Correlation between LFI and the clinician assessment was modest (ρ=0.38) with high variability by hepatologist (ρ=0.26-0.70). At a median of 11 months, 102 (19%) died/were delisted. Both the LFI (hazard ratio (HR) 2.2, 95% confidence interval (CI) 1.7-2.9) and clinician assessment (HR 1.6, 95% CI 1.3-1.9) were associated with adjusted waitlist mortality risk (P
- Published
- 2018
227. Gastroenterologist and primary care perspectives on a post-endoscopy discharge policy: impact on clinic wait times, provider satisfaction and provider workload.
- Author
-
Selvig, Daniel, Sewell, Justin L, Tuot, Delphine S, and Day, Lukejohn W
- Subjects
Humans ,Endoscopy ,Gastrointestinal ,Patient Discharge ,Health Care Surveys ,Attitude of Health Personnel ,Personal Satisfaction ,Gastroenterology ,Waiting Lists ,Workload ,Referral and Consultation ,Primary Health Care ,San Francisco ,Female ,Male ,Physicians ,Primary Care ,Gastroenterologists ,Access to healthcare ,Endoscopy ,Provider satisfaction ,Quality of care ,Wait times ,Library and Information Studies ,Nursing ,Public Health and Health Services ,Health Policy & Services - Abstract
BackgroundTo reduce unnecessary ambulatory gastroenterology (GI) visits and increase access to GI care, San Francisco Health Network gastroenterologists and primary care providers implemented guidelines in 2013 that discharged certain patients back to primary care after endoscopy with formal written recommendations. This study assesses the longer-term impact of this policy on GI clinic access, workflow, and provider satisfaction.MethodsAn email-based survey assessed gastroenterologist and primary care provider (PCP) opinions about the discharge process. Administrative data and chart review were used to assess clinic access, intervention fidelity, and re-referral rates.Results102/299 (34%) of PCPs and 5/7 (71%) of gastroenterologists responded to the survey. 74% of PCPs and 100% of gastroenterologists were satisfied or very satisfied with the discharge process. 80% of gastroenterologists believed the discharge process decreased their workload, while 53.5% of primary care providers believed it increased their workload. 6.7% of patients discharged to primary care in 2013 had re-referrals to GI. Wait time for the third-next-available new outpatient GI clinic appointment had previously decreased from 158 days (2012, pre-intervention) to 74 days (2013, post-intervention). In 2015, wait time was 19 days (p
- Published
- 2018
228. SMART method for parenteral nutrition review for gastroenterologists.
- Author
-
Oliveira, Stephanie B.
- Subjects
PARENTERAL feeding ,GASTROENTEROLOGISTS ,NUTRITION ,SHORT bowel syndrome ,CHILD nutrition - Abstract
Keywords: education; nutrition; nutrition support teams; parenteral formulas/compounding EN education nutrition nutrition support teams parenteral formulas/compounding 456 458 3 05/09/23 20230501 NES 230501 What is known? Gastroenterology trainees are typically concerned about not learning to write PN prescriptions during their training, which, in reality, is not necessary.[[1], [3]] Physicians will typically have a role of PN verification either formally or in their routine practice when evaluating patients. The calcium and phosphorus doses are appropriate, and the solubility curve is normal (this can be determined by plotting the values at the standard calcium/phosphorus solubility curve, or by alerts that are prompted by some of the electronic PN ordering systems). [Extracted from the article]
- Published
- 2023
- Full Text
- View/download PDF
229. Recurrent Iliopsoas Abscesses Due to Migrated Appendicular Fecalith: A Case Report and Review of the Literature.
- Author
-
Nagai, Sota, Hachiya, Kurenai, Takeda, Hiroki, Kawabata, Soya, Ikeda, Daiki, Tsukamoto, Tetsuya, Kaneko, Shinjiro, and Fujita, Nobuyuki
- Subjects
- *
ILIOPSOAS muscle , *APPENDICITIS , *ABSCESSES , *LITERATURE reviews , *PSOAS muscles , *GASTROENTEROLOGISTS - Abstract
Case: Appendicular fecaliths have been reported to migrate to nearby organs before or during surgical treatment and become a late source of infection. We report an extremely rare case of recurrent iliopsoas abscesses caused by appendicular fecaliths that have migrated to the psoas muscle before or during the previous appendicectomy for acute appendicitis. In this case, surgical removal of fecaliths cured the iliopsoas abscess. Conclusion: Orthopaedic surgeons and gastroenterologists should remember that appendicular fecaliths that migrated into the iliopsoas muscle may cause late-onset iliopsoas abscesses. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
230. Interactive Inflammatory Bowel Disease Biologics Decision Aid Does Not Improve Patient Outcomes Over Static Education: Results From a Randomized Trial.
- Author
-
Almario, Christopher V., van Deen, Welmoed K., Chen, Michelle, Gale, Rebecca, Sidorkiewicz, Stéphanie, Choi, So Yung, Bonthala, Nirupama, Ha, Christina, Syal, Gaurav, Dupuy, Taylor, Liu, Xiaoyu, Melmed, Gil Y., and Spiegel, Brennan M.R.
- Subjects
- *
INFLAMMATORY bowel diseases , *CROHN'S disease , *PATIENTS' attitudes , *BIOLOGICALS , *TREATMENT effectiveness , *GASTROENTEROLOGISTS - Abstract
INTRODUCTION: To support shared decision-making (SDM) between patients and providers surrounding biologic treatments, we created IBD&me (ibdandme.org)—a freely available, unbranded, interactive decision aid. We performed a multicenter comparative effectiveness trial comparing the impact of IBD&me on SDM vs a biologics fact sheet developed by the Crohn's & Colitis Foundation. METHODS: We enrolled patients with inflammatory bowel disease (IBD) being seen at a clinic within IBD Qorus—a multicenter adult IBD learning health system—between March 5, 2019, and May 14, 2021. Eligible patients included those with recent IBD-related symptoms who reported that they wanted to discuss biologics with their provider during their upcoming visit. Patients were randomized 1:1 using stratified block randomization and received an e-mail 1 week before their visit inviting them to review either IBD&me or a fact sheet. The primary outcome was patient perception of SDM as measured by the 9-Item SDM Questionnaire (0–100 scale; higher = better); the Student t test was used to compare outcomes between arms. RESULTS: Overall, 152 patients were randomized (biologics fact sheet 75, IBD&me 77); most patients had Crohn's disease (66.4%) and were biologic-experienced (82.9%). No differences were seen between groups regarding SDM (fact sheet 72.6 ± 25.6, IBD&me 75.0 ± 20.8; P =.57). Most patients stated they would be likely to recommend the fact sheet (79.6%) or IBD&me (84.9%; P =.48) to another patient with IBD. DISCUSSION: No differences in outcomes were seen between IBD&me and the biologics fact sheet in this comparative effectiveness study; patients reported high satisfaction with both resources. Further study, particularly among biologic naïve patients, is needed to determine the utility of interactive components to IBD decision aids. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
231. People Living with Inflammatory Bowel Disease Want Multidisciplinary Healthcare: A Qualitative Content Analysis.
- Author
-
Feeney, Meg, Chur-Hansen, Anna, and Mikocka-Walus, Antonina
- Subjects
- *
INFLAMMATORY bowel diseases , *MEDICAL personnel , *CONTENT analysis , *MEDICAL care , *GASTROENTEROLOGISTS - Abstract
This study reports on the preferences of people with inflammatory bowel disease (IBD) for their healthcare. Overall, 477 people with IBD responded to an open-ended survey question within a larger study. We qualitatively content-analysed these responses with open coding using NVivo. Respondents expressed a desire for (1) better communication, (2) multidisciplinary care, (3) better treatment, services and specialist care, (4) whole person care, (5) health promotion, (6) proactive healthcare, (7) fewer administrative issues and (8) improved hospital experience. Patients with IBD want patient-centred, multidisciplinary care. Healthcare professionals should facilitate patients' access to proactive care. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
232. In vivo spectroscopy: optical fiber probes for clinical applications.
- Author
-
Barik, Ajaya Kumar, M, Sanoop Pavithran, Lukose, Jijo, Upadhya, Rekha, Pai, Muralidhar V, Kartha, V.B., and Chidangil, Santhosh
- Subjects
OPTICAL spectroscopy ,MAGNETIC resonance imaging ,OPTICAL fibers ,TECHNOLOGY assessment ,LASER spectroscopy ,DIAGNOSTIC ultrasonic imaging personnel ,GASTROENTEROLOGISTS ,FIRE detectors - Abstract
Fiber optic probe-based in vivo spectroscopy techniques are fast and highly objective methods for intraoperative diagnoses and minimally invasive surgical interventions for all procedures where endoscopic observations are carried out for cancers of different types. The Raman spectral features provide molecular fingerprint-type information and can reveal the subjects' pathological state in label-free manner, making endoscopy multiplexed fiber optic probe-based devices with the potential for translation from bench to bedside for routine applications. This review provides a general overview of different fiber-optic probes for in vivo measurements with emphasis on Raman spectroscopy for biomedical application. Various aspects such as fiber-optic probe, radiation source, detector, and spectrometer for extracting optimum spectral features have also been discussed. Optical spectroscopy-based fiber probe systems with 'Chip-on-Tip' technology, combined with machine learning, can in the near future, become a complementary diagnostic tool to magnetic resonance imaging (MRI), computed tomography (CT) scan, ultrasound, etc. Hyperspectral imaging and fluorescence-based devices are in the advanced stage of technology readiness level (TRL), and with advances in lasers and miniature spectroscopy systems, probe-based Raman devices are also coming up. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
233. Vaccination Updates for Patients With Inflammatory Bowel Disease.
- Author
-
Farraye, Francis A.
- Subjects
INFECTION prevention ,INFLAMMATORY bowel diseases ,IMMUNIZATION ,PROFESSIONS ,PNEUMOCOCCAL vaccines ,VACCINE effectiveness ,HERPES zoster vaccines ,INFORMATION resources ,IMMUNOSUPPRESSIVE agents ,HEPATITIS B vaccines ,HEALTH promotion ,GASTROENTEROLOGISTS - Published
- 2022
234. Gastroenterologist's Guide to Gastrostomies.
- Author
-
Abdelfattah, Thaer and Kaspar, Matthew
- Subjects
- *
FEEDING tubes , *GASTROENTEROLOGISTS - Abstract
Gastroenterologists are frequently consulted for evaluation feeding tube placement, or for management of complications in an existing feeding tube. Though a frequent topic of consultation for GI Fellows, there are few comprehensive resources for feeding tube placement and troubleshooting available. In this review, we discuss different types of feeding tubes, when each should be considered, and various methods and techniques for placement. Considerations for when one type, method, technique, or specialty may be preferred over the other will be discussed. Additionally, we discuss management of the many complications of indwelling feeding tubes. Our goal is to create a comprehensive review for gastroenterologists to cover clinically relevant questions related to feeding tube placement and management. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
235. Gastroenterology Practice Consolidation Between 2012 and 2020.
- Author
-
Griffin, Zachary D., Hogan, Jacob, Pollock, Jordan R., Moore, Michael L., and Mehta, Dhruv
- Subjects
- *
GASTROENTEROLOGISTS , *GASTROENTEROLOGY , *ECONOMIES of scale , *PRIVATE equity , *PHYSICIANS - Abstract
Introduction: Multiple studies have indicated physicians are practicing medicine in increasingly larger groups. However, specialty-specific data on the extent of consolidation are lacking for many specialties, including gastroenterology. We aim to determine the extent of consolidation for gastroenterology in recent years. Methods: The Physician Compare database was used to gather information at both an individual and group level. This information included location and number of providers for each group. Cochran-Armitage tests were used to test for differences between practice sizes in 2012 and 2020. Results: Between 2012 and 2020, the number of physicians increased from 12,766 to 13,934, while the total number of practices decreased from 4517 to 3865. The total number of physicians who practice in groups of less than 9 physicians decreased by 23.9%, while the total number of physicians in practices of 100 + increased by 16.8%. Discussion: Significant consolidation has occurred in the field of gastroenterology in every geographic region of the USA. The causes of consolidation are multi-faceted and include the legislative environment, private equity and hospital acquisition of private groups, individual physician lifestyle preferences, and economic benefits of economies of scale. However, the consequences of consolidation are still unclear. Conclusion: Over the last eight years, gastroenterologists have been practicing in increasingly larger groups. This trend has been consistent in each area of the country. Future research should focus on the impact of consolidation on patient care and physician wellbeing. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
236. Survey of barriers to adherence to international inflammatory bowel disease guidelines: does gastroenterologists' confidence translate to high adherence?
- Author
-
Kanazaki, Ria, Smith, Ben, Girgis, Afaf, Descallar, Joseph, and Connor, Susan
- Subjects
- *
INFLAMMATORY bowel disease treatment , *STATISTICS , *PROFESSIONS , *CONFIDENCE intervals , *CROSS-sectional method , *MULTIVARIATE analysis , *PHYSICIANS' attitudes , *FISHER exact test , *REGRESSION analysis , *MEDICAL protocols , *SURVEYS , *DESCRIPTIVE statistics , *DATA analysis software , *ODDS ratio , *GASTROENTEROLOGISTS - Abstract
Background: Despite the availability of evidence‐based inflammatory bowel disease (IBD) guidelines, suboptimal care persists. There is little published research assessing barriers to IBD guideline adherence. Aim: To identify barriers to IBD guideline adherence including gastroenterologists' knowledge and attitudes towards guidelines. Methods: An online cross‐sectional survey of 824 Australian gastroenterologists was conducted from April to August 2018, with 198 (24%) responses. A novel survey was developed that was informed by the theoretical domain's framework. Results: Confidence in guideline recommendations was high; however, referral to them was low. The European Crohn's and Colitis Organisation guidelines were referred to most commonly (43.6%). In multivariate analysis, significant predictors of frequent versus infrequent guideline referral were: high confidence in the guideline (odds ratio (OR) 7.70; 95% confidence interval (CI): 2.43–24.39; P = 0.001), and low (≤10 years) clinical experience (OR 3.62; 95% CI: 1.11–11.79; P = 0.03). The most common barriers to guideline adherence were not having time (62%), followed by guideline specifics being difficult to remember (61%). Low confidence was reported in managing pregnancy and IBD (34%) and loss of response to therapy (29%). High confidence was reported in managing immunomodulators; however, only 43% answered the associated knowledge question correctly. Conclusion: Although gastroenterologists have high confidence in guidelines, they use them infrequently, primarily due to specifics being difficult to remember and lack of time. Self‐reported confidence in an area of IBD management does not always reflect knowledge. An intervention targeting these barriers, for example, computer‐based clinical decision support tools, might improve adherence and standardise care. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
237. Nonalcoholic steatohepatitis medical patient journey from the perspective of hepatologists, gastroenterologists and patients: a cross-sectional survey.
- Author
-
Rinella, Mary, Cryer, Donna R., Articolo, Amy, Fisher, Travis, Schneider, Jennifer, and Nadolsky, Karl
- Subjects
- *
FATTY liver , *NON-alcoholic fatty liver disease , *GASTROENTEROLOGISTS , *PATIENT compliance , *MEDICAL personnel , *PATIENT surveys - Abstract
Background: Nonalcoholic steatohepatitis (NASH), the inflammatory subtype of nonalcoholic fatty liver disease, is underdiagnosed and expected to become the leading indication for liver transplant in the United States. We aimed to understand the medical journey of patients with NASH and role of hepatologists/gastroenterologists in diagnosing and treating patients with NASH. Methods: A United States population-based cross-sectional online survey was completed by 226 healthcare professionals (HCPs) who treat patients with NASH and 152 patients with NASH; this study focuses on the patient and 75 hepatologist/gastroenterologist HCP respondents. Tests of differences (chi square, t-tests) between respondent types were performed using SPSS. Results: Most patients reported receiving their diagnosis of NASH from a hepatologist (37%) or gastroenterologist (26%). Hepatologists/gastroenterologists were more likely than other HCPs to use FibroScan (transient elastography) to diagnose NASH and were more likely to distinguish between NASH with or without fibrosis. Hepatologists/gastroenterologists (68%) and patients (52%) agree that hepatologists/gastroenterologists are the primary coordinators of NASH care. The majority of hepatologists/gastroenterologists (85%) are aware of American Association for the Study of Liver Diseases (AASLD) clinical practice guidance, and 86% of those aware consider them when diagnosing patients with NASH. Hepatologists/gastroenterologists most frequently recommended exercise (86%), diet (70%), and supplements (58%) for ongoing management of NASH. Pharmaceutical medications for comorbidities were prescribed by a minority of hepatologists/gastroenterologists for their patients with NASH. Hepatologists/gastroenterologists cite difficulty (67%) or unwillingness (64%) to adhere to lifestyle changes as primary reasons patients with NASH discontinue NASH treatment. Conclusions: Hepatologists/gastroenterologists are considered the coordinators of NASH care. While recognizing that patient adherence to lifestyle changes is the basis for successful treatment, important barriers limit successful implementation. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
238. How to Implement the 3-Phase FODMAP Diet Into Gastroenterological Practice.
- Author
-
Sultan, Nessmah, Varney, Jane E., Halmos, Emma P., Biesiekierski, Jessica R., Yao, Chu K., Muir, Jane G., Gibson, Peter R., and Tuck, Caroline J.
- Subjects
- *
LOCAL delivery services , *IRRITABLE colon , *DIET , *GASTROENTEROLOGISTS , *MEDICAL personnel , *DIETITIANS - Abstract
Background/Aims The 3-phase fermentable oligo-, di-, mono-saccharides, and polyols (FODMAP) diet has shown a high level of efficacy in irritable bowel syndrome, largely based on dietitian delivered education. However, access to dietitians can be limited, and challenges exist when applying the diet to a wide range of cultures, such as limited FODMAP analysis of local foods. This review aims to discuss ways to optimally use the FODMAP diet in practice in a wide range of cultures, directed at gastroenterologists from a dietitian's perspective. Methods Recent literature was analysed via search databases including Medline, CINAHL, PubMed and Scopus. Results The dietetic process involves detailed assessment and follow-up through the 3 stages of the FODMAP diet (restriction, re-introduction, and long-term maintenance). Emerging evidence suggests the diet can be delivered by other health professionals such as the gastroenterologist or nurse, but training on how to do so successfully would be needed. Self-guided approaches through use of technology or specialised food delivery services may be an alternative when dietitians are not available, but efficacy data is limited. Regardless of delivery mode, nutritional and psychological risks of the diet must be mitigated. Additionally, culturally appropriate education must be provided, with accommodations necessary when the FODMAP content of local foods are unknown. Conclusion While the diet has shown improved irritable bowel syndrome outcomes across studies, it is important to acknowledge the essential role of dietitians in implementing, tailoring, and managing the diet to achieve the best outcome for each individual. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
239. Telemedicine based on patient-reported outcomes in management of patients with inflammatory bowel disease in a real-life setting – a before and after cohort study.
- Author
-
Appel, Charlotte W., Pedersen, Sarah Christine, Nielsen, Amalie Søgaard, and Larsen, Birgit Furstrand
- Subjects
- *
INFLAMMATORY bowel diseases , *PATIENT reported outcome measures , *MEDICAL care use , *WILCOXON signed-rank test , *COHORT analysis , *GASTROENTEROLOGISTS - Abstract
Avoidable appointments and increasing incidence of inflammatory bowel disease (IBD) call for alternative ways of organizing outpatient visits. In controlled studies, telemedicine including patient reported outcome (PRO) has shown to improve outcomes in IBD and reduce health care utilization. However, we lack studies of telemedicine implemented in everyday practice. We therefore described use of a PRO-based telemedicine follow-up (AmbuIBD) in a real-life setting and investigated the effect on outpatient visits and hospital admissions. We conducted a cohort study including patients with IBD in an outpatient clinic at a Danish regional hospital August 2018. Data included extracts from the Patient Administration System and the AmbuFlex system between 2017 and August 2018, plus questionnaire data from clinicians. Descriptive statistics were used to describe use of AmbuIBD and differences between before and after results were tested with Wilcoxon's signed-rank test. Of 848 patients in outpatient care, 77% were included in AmbuIBD. Most patients were set to answer a PRO questionnaire once a year (n = 407, 62%), and 66% of 1913 answered questionnaires were handled with no further contact. AmbuIBD was well accepted by clinicians. Outpatient visits the year after AmbuIBD compared to the year before were reduced with 14% (p ≤.001). The largest reduction was for patients with mild or no disease activity (45%, p ≤.001). No difference was found for hospital admissions. AmbuIBD is feasible and well accepted when implemented in an outpatient clinic. More than half of patients are only followed by questionnaire, and we found a reduction in outpatient visits. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
240. Current Applications of Telemedicine in Gastroenterology.
- Author
-
Fung, Brian M., Markarian, Eric, Serper, Marina, and Tabibian, James H.
- Subjects
- *
MEDICAL personnel , *INFLAMMATORY bowel diseases , *GASTROENTEROLOGISTS , *TELEMEDICINE , *PEDIATRIC gastroenterology , *CELIAC disease , *GASTROENTEROLOGY - Abstract
Telemedicine generally refers to the use of technology to communicate with patients and provide health care from a distance. Advances in technology, specifically computers, cellphones, and other mobile devices, have facilitated healthcare providers' growing ability to virtually monitor and mentor patients. There has been a progressive expansion in the use of telemedicine in the field of gastroenterology (GI), which has been accelerated by the COVID-19 pandemic. In this review, we discuss telemedicine—its history, various forms, and limitations—and its current applications in GI. Specifically, we focus on telemedicine in GI practice in general and specific applications, including the management of inflammatory bowel disease, celiac disease, and colorectal cancer surveillance and its use as an aid in endoscopic procedures. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
241. Clinical practice of Helicobacter pylori infection management by gastroenterologists in secondary and tertiary hospitals: A stratified sampling cross‐sectional survey.
- Author
-
Zhang, Wen Lin, Li, Yue Yue, Liu, Jing, Wang, Juan, Wan, Meng, Lin, Bo Shen, Lin, Min Juan, Ding, Yu Ming, Kong, Qing Zhou, Wang, Shao Tong, Duan, Miao, Han, Zhong Xue, Ji, Rui, Zuo, Xiu Li, and Li, Yan Qing
- Subjects
- *
HELICOBACTER pylori infections , *GASTROENTEROLOGISTS , *HOSPITALS , *HELICOBACTER pylori , *BREATH tests - Abstract
Objective: To investigate the management of Helicobacter pylori (H. pylori) infection by gastroenterologists from secondary and tertiary hospitals in Shandong Province, China, where there is a high prevalence of H. pylori infection. Methods: A questionnaire‐based, stratified sampling survey was conducted from June 1 to August 30, 2021. The ratio of secondary to tertiary hospitals was set at 2:1. An electronic questionnaire was sent to the gastroenterologists via the WeChat platform. Results: A total of 89.09% (1053/1182) gastroenterologists were included. Overall, 34.19% and 60.59% of gastroenterologists recommended screening for and treating H. pylori infection in patients without any competing factors. The most preferred testing method in secondary and tertiary hospitals was the 13C‐urea breath test (53.92% and 80.48%), but the reexamination rate of results close to the cut‐off value was low (55.10% and 59.48%). Gastroenterologists preferred bismuth‐containing quadruple therapy (secondary and tertiary hospitals: 96.67% and 98.53%), but the antibiotic combination prescribed for patients with penicillin allergy was suboptimal in secondary hospitals. The overall post‐treatment follow‐up rate was 64.58%, and gastroenterologists in secondary hospitals were more proactive than those in tertiary hospitals (69.41% vs 60.04%, P = 0.001). Less than 80% of gastroenterologists emphasized the importance of post‐treatment reexamination to their patients. Only a minority of gastroenterologists in secondary and tertiary hospitals (30.79% and 34.36%) achieved acceptable eradication rates (exceeding 80%). Conclusions: Deficiencies exist in gastroenterologists from secondary and tertiary hospitals, and the H. pylori eradication rate is relatively low. Training programs for gastroenterologists are warranted to strengthen their comprehension of guidelines. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
242. How should radiation exposure be handled in fluoroscopy‐guided endoscopic procedures in the field of gastroenterology?
- Author
-
Takenaka, Mamoru, Hosono, Makoto, Hayashi, Shiro, Nishida, Tsutomu, and Kudo, Masatoshi
- Subjects
- *
RADIATION exposure , *RADIATION protection , *GASTROENTEROLOGY , *GASTROENTEROLOGISTS , *RADIOLOGISTS - Abstract
Fluoroscopy‐guided endoscopic procedures (FGEPs) are rapidly gaining popularity in the field of gastroenterology. Radiation is a well‐known health hazard. Gastroenterologists who perform FGEPs are required to protect themselves, patients, as well as nurses and radiologists engaged in examinations from radiation exposure. To achieve this, all gastroenterologists must first understand and adhere to the International Commission on Radiological Protection Publication. In particular, it is necessary to understand the three principles of radiation protection (Justification, Optimization, and Dose Limits), the As Low As Reasonably Achievable principle, and the Diagnostic Reference Levels (DRLs) according to them. This review will mainly explain the three principles of radiation exposure protection, DRLs, and occupational radiological protection in interventional procedures while introducing related findings. Gastroenterologists must gain knowledge of radiation exposure protection and keep it updated. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
243. Impact of Clinician Linkage on Unequal Access to High-Volume Hospitals for Colorectal Cancer Surgery.
- Author
-
McDermott, James, Wang, Haijun MS, DeLia, Derek, Sweeney, Matthew MS, Bayasi, Mohammed FACS, Unger, Keith, Stein, David E, Al-Refaie, Waddah B FACS, Wang, Haijun, Sweeney, Matthew, Bayasi, Mohammed, and Al-Refaie, Waddah B
- Subjects
- *
HOSPITALS , *COLORECTAL cancer , *RECTAL cancer , *GASTROENTEROLOGISTS , *COLON (Anatomy) , *FERRANS & Powers Quality of Life Index , *MEDICAL care , *IMPACT of Event Scale , *QUESTIONNAIRES , *MEDICAL specialties & specialists ,RECTUM tumors - Abstract
Background: Understanding drivers of persistent surgical disparities remains an important area of cancer care delivery and policy. The degree to which clinician linkages contribute to disparities in access to quality colorectal cancer surgery is unknown. Using hospital surgical volume as a proxy for quality, the study team evaluated how clinician linkages impact access to colorectal cancer surgery at high-volume hospitals (HVHs).Study Design: Maryland's Health Services Cost Review Commission was used to evaluate 6,909 patients who underwent colon or rectal cancer operations from 2013 to 2018. Two linkages based on patient sharing were examined separately for colon and rectal cancer surgery: (1) from primary care clinicians to specialists (gastroenterologist or medical oncologist) and (2) from specialists to surgeons (general or colorectal). A referral link was defined as 9 or more shared patients between 2 clinicians. Adjusted regression models examined associations between referral links and odds of receiving colon or rectal cancer operations at HVHs.Results: The cohort included 5,645 colon and 1,264 rectal cancer patients across 52 hospitals. Every additional referral link between a primary care clinician and a specialist connected to a HVH was associated with a 12% and 14% increased likelihood of receiving colon (odds ratio [OR] 1.12, CI 1.07 to 1.17) and rectal (OR 1.14, CI 1.08 to 1.20]) cancer operations at a HVH, respectively. Every additional referral link between a specialist and a surgeon at a HVH was associated with at least a 25% increased likelihood of receiving colon (OR 1.28, CI 1.20 to 1.36) and rectal (OR 1.25, CI 1.15 to 1.36) cancer operation at a HVH.Conclusions: Patients of clinicians with linkages to HVHs are more likely to have their colorectal cancer operations at these hospitals. These findings suggest that policy interventions targeting clinician relationships are an important step in providing equitable surgical care. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
244. COVID-19 Vaccination Among Individuals With Inflammatory Bowel Disease: Perception, Efficacy, and Safety.
- Author
-
Weaver, Kimberly N., Kappelman, Michael D., and Long, Millie D.
- Subjects
DRUG efficacy ,INFLAMMATORY bowel diseases ,COVID-19 ,IMMUNIZATION ,COVID-19 vaccines ,PATIENTS' attitudes ,VACCINE hesitancy ,IMMUNITY ,PATIENT education ,PATIENT safety ,GASTROENTEROLOGISTS - Abstract
The COVID-19 pandemic, caused by SARS-CoV-2, has been the most significant global health crisis of the past century. The development of safe and effective vaccines has led to a reduction in COVID-19-related hospitalizations and deaths; however, the clinical trials that led to US Food and Drug Administration Emergency Use Authorization and/or approval of the vaccines in the United States did not include individuals with inflammatory bowel disease (IBD). Because individuals with IBD are commonly treated with immunosuppressive medications, there had been concern for reduced vaccine efficacy in this population. This article provides an overview of the peer-reviewed literature addressing COVID-19 vaccination in individuals with IBD; details the perceptions of patients with IBD of COVID-19 vaccines, including how gastroenterologists can help to reduce vaccine hesitancy; and describes the humoral immune response to COVID-19 vaccines, with a majority of patients with IBD seroconverting following complete vaccination regardless of medication exposure. Additionally, low rates of IBD flare and similar rates of vaccine-related adverse events to those in the general population are described. Finally, the article provides current recommendations from the Centers for Disease Control and Prevention for COVID-19 vaccination in individuals with IBD. [ABSTRACT FROM AUTHOR]
- Published
- 2022
245. Estimating the environmental impact of disposable endoscopic equipment and endoscopes.
- Author
-
Namburar, Sathvik, von Renteln, Daniel, Damianos, John, Bradish, Lisa, Barrett, Jeanne, Aguilera-Fish, Andres, Cushman-Roisin, Benoit, and Pohl, Heiko
- Subjects
ENDOSCOPES ,FECAL occult blood tests ,DISPOSABLE medical devices ,GASTROENTEROLOGISTS ,HEALTH facilities ,CLIMATE change & health ,DRUG disposal - Published
- 2022
- Full Text
- View/download PDF
246. Comparative evaluation of a language model and human specialists in the application of European guidelines for the management of inflammatory bowel diseases and malignancies.
- Author
-
Ghersin I, Weisshof R, Koifman E, Bar-Yoseph H, Ben Hur D, Maza I, Hasnis E, Nasser R, Ovadia B, Dror Zur D, Waterman M, and Gorelik Y
- Subjects
- Humans, Europe, Language, Gastroenterologists, Colonoscopy standards, Gastroenterology standards, Inflammatory Bowel Diseases therapy, Practice Guidelines as Topic, Guideline Adherence, Colorectal Neoplasms therapy, Colorectal Neoplasms diagnosis
- Abstract
Background: Society guidelines on colorectal dysplasia screening, surveillance, and endoscopic management in inflammatory bowel disease (IBD) are complex, and physician adherence to them is suboptimal. We aimed to evaluate the use of ChatGPT, a large language model, in generating accurate guideline-based recommendations for colorectal dysplasia screening, surveillance, and endoscopic management in IBD in line with European Crohn's and Colitis Organization (ECCO) guidelines., Methods: 30 clinical scenarios in the form of free text were prepared and presented to three separate sessions of ChatGPT and to eight gastroenterologists (four IBD specialists and four non-IBD gastroenterologists). Two additional IBD specialists subsequently assessed all responses provided by ChatGPT and the eight gastroenterologists, judging their accuracy according to ECCO guidelines., Results: ChatGPT had a mean correct response rate of 87.8%. Among the eight gastroenterologists, the mean correct response rates were 85.8% for IBD experts and 89.2% for non-IBD experts. No statistically significant differences in accuracy were observed between ChatGPT and all gastroenterologists ( P =0.95), or between ChatGPT and the IBD experts and non-IBD expert gastroenterologists, respectively ( P =0.82)., Conclusions: This study highlights the potential of language models in enhancing guideline adherence regarding colorectal dysplasia in IBD. Further investigation of additional resources and prospective evaluation in real-world settings are warranted., Competing Interests: The authors declare that they have no conflict of interest., (Thieme. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
247. Performance Improvement and Artificial Intelligence (AI) Emerge to Bridge the Gap for Exceptional Gastroenterology Physician Onboarding.
- Author
-
Rudnick JD Jr, Back MJ, Turner JA Jr, and Vezina ML
- Subjects
- Humans, Gastroenterologists, Artificial Intelligence, Gastroenterology
- Published
- 2024
- Full Text
- View/download PDF
248. Metabolic dysfunction-associated steatotic liver disease and diabetes: the cross-talk between hepatologist and diabetologist.
- Author
-
Yeh ML, Huang JF, Dai CY, Huang CF, Yu ML, and Chuang WL
- Subjects
- Humans, Non-alcoholic Fatty Liver Disease metabolism, Non-alcoholic Fatty Liver Disease therapy, Gastroenterologists, Risk Factors, Prognosis, Diabetes Mellitus, Type 2 complications, Diabetes Mellitus, Type 2 metabolism, Insulin Resistance
- Abstract
Introduction: Metabolic dysfunction-associated steatotic liver disease (MASLD) and type 2 diabetes mellitus (DM) are the most prevalent metabolic disorders globally. The numbers affected in both disorders are also rapidly increasing with alarming trends in children and young adults., Areas Covered: Insulin resistance (IR) and the subsequent metabolic dysregulation are the fundamental pathogenesis pathways of the prevalent metabolic disorders. The interaction and impacts are bidirectional between MASLD and DM in terms of disease mechanisms, disease course, risks, and prognosis. There's a pressing issue for highlighting the links between MASLD and DM for both care specialists and primary care providers. The review collected the scientific evidence addressing the mutual interactions between the two disorders. The strategies for surveillance, risk stratification, and management are discussed in a practical manner. It also provides individualized viewpoints of patient care in hepatology and diabetology., Expert Opinion: Both MASLD and DM shared similar disease mechanisms, and affected the disease development and progression in a bidirectional manner. The high prevalence and the cross-link between the two disorders raise clinical issues from awareness, screening, risk stratification, optimal referral, to appropriate management for primary care providers.
- Published
- 2024
- Full Text
- View/download PDF
249. Sexual health in adolescents with inflammatory bowel disease - The paediatric gastroenterologists' point of view.
- Author
-
Anafy A, Cohen S, Matar M, Shouval DS, Shamir R, and Weintraub Y
- Subjects
- Humans, Adolescent, Male, Female, Practice Patterns, Physicians' statistics & numerical data, Sexually Transmitted Diseases, Gastroenterologists, Surveys and Questionnaires, Israel, Pediatrics, Sexual Behavior, Gastroenterology, Inflammatory Bowel Diseases complications, Sexual Health
- Abstract
Aim: Although sexual health (SH) impairment and sexually transmitted infections (STI) are occasionally encountered in patients with inflammatory bowel disease (IBD), paediatric gastroenterologists (PedGI) do not often discuss these issues. Literature about SH in the paediatric IBD population is limited. We aimed to assess PedGI knowledge and common practice related to sexual advice and STI workups in patients with IBD., Methods: A questionnaire comprising 25 questions addressing sexual activity in youth, SH, recommendations, and workup for STI in adolescents with IBD was sent to all registered PedGI in Israel., Results: Fifty-two physicians completed the questionnaire (27 males,52%). Only 50% correctly predicted the mean age that Israeli youth start practicing sex. Seventy-five per cent responded that providers should discuss sexual activity with their patients, but only 19% do so, most often in response to a patient's query. Ninety six percent answered that they do not have enough knowledge about SH in IBD. Finally, only 2% obtain rectal swabs for STI in patients with refractory proctitis., Conclusion: Sexual issues and recommendations are not routinely discussed by the majority of PedGI in paediatric IBD clinics. Providers should obtain more knowledge in the field and initiate discussion of these issues with adolescent patients with IBD., (© 2024 The Author(s). Acta Paediatrica published by John Wiley & Sons Ltd on behalf of Foundation Acta Paediatrica.)
- Published
- 2024
- Full Text
- View/download PDF
250. Palliative care and end stage liver disease: A survey study comparing perspectives of hepatology and palliative care physicians and clinical scenarios that could require palliative care intervention.
- Author
-
Oliveira HM, Ramos JP, Rego F, and Nunes R
- Subjects
- Humans, Cross-Sectional Studies, Male, Female, Gastroenterologists, Attitude of Health Personnel, Middle Aged, Adult, Surveys and Questionnaires, Physicians psychology, Palliative Care, End Stage Liver Disease therapy, Gastroenterology
- Abstract
Background and Aims: The prevalence and mortality of chronic liver disease has risen significantly. In end stage liver disease (ESLD) the survival of patients is approximately 2 years. Despite the poor prognosis and high symptom burden of these patients, integration of palliative care is reduced. We aim to analyze the agreement between palliative care and hepatology physicians of clinical scenarios that could require palliative care intervention., Methods: A cross-sectional study was conducted. Palliative care and hepatology physicians were surveyed. Using a five-point Likert scale, their perceptions of palliative care in ESLD were rated. Their agreement in clinical scenarios that could require palliative care intervention were evaluated. Analyses were conducted to assess any differences by primary role (hepatology vs. palliative care) and length of practice (<10 years vs. 10 years)., Results: A total of 123 responses were obtained: 52% from palliative care and 48% from hepatology. The majority (66.7%) work in the field for up to ten years. There was a great consensus in 4 of the 8 clinical scenarios. In scenarios with less consensus, the area of activity and length of practice influence the reliance of physicians on palliative care. Involvement of palliative care in ESLD was considered "rare" by 30% and 61% consider difficult to predict the prognosis. More than 90% support medical training in both areas of activity., Conclusion: The current involvement of palliative care is considered low, but there are clinical conditions that reveal a clear consensus and there's a unanimous view of the relevance of training., Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper., (Copyright © 2024 The Author(s). Published by Elsevier Masson SAS.. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.